Publications

  1. Ogony J, Hoskin TL, Stallings-Mann M, Winham S, Brahmbhatt R, Arshad MA, Kannan N, Pena A, Allers T, Brown A, Sherman ME, Visscher DW, Knutson KL, Radisky DC, Degnim AC. Immune cells are increased in normal breast tissues of BRCA1/2 mutation carriers. Breast Cancer Res Treat. 2023 Jan; 197 (2):277-285 Epub 2022 Nov 16
    View PubMed
  2. Manzo J, Puhalla S, Pahuja S, Ding F, Lin Y, Appleman L, Tawbi H, Stoller R, Lee JJ, Diergaarde B, Kiesel BF, Yu J, Tan AR, Belani CP, Chew H, Garcia AA, Morgan RJ, Wahner Hendrickson AE, Visscher DW, Hurley RM, Kaufmann SH, Swisher EM, Oesterreich S, Katz T, Ji J, Zhang Y, Parchment RE, Chen A, Duan W, Giranda V, Shepherd SP, Ivy SP, Chu E, Beumer JH, ETCTN-8282 study team. A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovarian or triple-negative breast cancer. Cancer Chemother Pharmacol. 2022 May; 89 (5):721-735 Epub 2022 Apr 18
    View PubMed
  3. de Bel T, Litjens G, Ogony J, Stallings-Mann M, Carter JM, Hilton T, Radisky DC, Vierkant RA, Broderick B, Hoskin TL, Winham SJ, Frost MH, Visscher DW, Allers T, Degnim AC, Sherman ME, van der Laak JAWM. Automated quantification of levels of breast terminal duct lobular (TDLU) involution using deep learning. NPJ Breast Cancer. 2022 Jan 19; 8 (1):13
    View PubMed
  4. Wahner Hendrickson AE, Visscher DW, Hou X, Goergen KM, Atkinson HJ, Beito TG, Negron V, Lingle WL, Bruzek AK, Hurley RM, Wagner JM, Flatten KS, Peterson KL, Schneider PA, Larson MC, Maurer MJ, Kalli KR, Oberg AL, Weroha SJ, Kaufmann SH. CHFR and Paclitaxel Sensitivity of Ovarian Cancer. Cancers (Basel). 2021 Nov 30; 13 (23)
    View PubMed
  5. Kleinstern G, Scott CG, Tamimi RM, Jensen MR, Pankratz VS, Bertrand KA, Norman AD, Visscher DW, Couch FJ, Brandt K, Shepherd J, Wu FF, Chen YY, Cummings SR, Winham S, Kerlikowske K, Vachon CM. Association of mammographic density measures and breast cancer "intrinsic" molecular subtypes. Breast Cancer Res Treat. 2021 May; 187(1):215-224. Epub 2021 Jan 04.
    View PubMed
  6. Yu J, Qin B, Moyer AM, Sinnwell JP, Thompson KJ, Copland JA 3rd, Marlow LA, Miller JL, Yin P, Gao B, Minter-Dykhouse K, Tang X, McLaughlin SA, Moreno-Aspitia A, Schweitzer A, Lu Y, Hubbard J, Northfelt DW, Gray RJ, Hunt K, Conners AL, Suman VJ, Kalari KR, Ingle JN, Lou Z, Visscher DW, Weinshilboum R, Boughey JC, Goetz MP, Wang L. Correction to: Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study. Breast Cancer Res. 2021 Mar 25; 23 (1):41
    View PubMed
  7. Polley MC, Leon-Ferre RA, Leung S, Cheng A, Gao D, Sinnwell J, Liu H, Hillman DW, Eyman-Casey A, Gilbert JA, Negron V, Boughey JC, Liu MC, Ingle JN, Kalari K, Couch F, Carter JM, Visscher DW, Nielsen TO, Goetz MP. A clinical calculator to predict disease outcomes in women with triple-negative breast cancer. Breast Cancer Res Treat. 2021 Feb; 185(3):557-566. Epub 2021 Jan 03.
    View PubMed
  8. Chatzopoulos K, Collins AR, Sotiriou S, Keeney MG, Visscher DW, Rivera M, Schembri-Wismayer DJ, Lewis JE, Greipp PT, Sukov WR, Chintakuntlawar AV, Price KA, Garcia JJ. Increased ERBB2 Gene Copy Numbers Reveal a Subset of Salivary Duct Carcinomas with High Densities of Tumor Infiltrating Lymphocytes and PD-L1 Expression. Head Neck Pathol. 2020 Dec; 14 (4):951-965 Epub 2020 Apr 29
    View PubMed
  9. Sherman ME, Vierkant RA, Kaggal S, Hoskin TL, Frost MH, Denison L, Visscher DW, Carter JM, Winham SJ, Jensen MR, Radisky DC, Vachon CM, Degnim AC. Breast Cancer Risk and Use of Nonsteroidal Anti-inflammatory Agents After a Benign Breast Biopsy. Cancer Prev Res (Phila). 2020 Nov; 13 (11):967-976 Epub 2020 July 27
    View PubMed
  10. Bodelon C, Oh H, Derkach A, Sampson JN, Sprague BL, Vacek P, Weaver DL, Fan S, Palakal M, Papathomas D, Xiang J, Patel DA, Linville L, Clare SE, Visscher DW, Mies C, Hewitt SM, Brinton LA, Storniolo AMV, He C, Chanock SJ, Garcia-Closas M, Gierach GL, Figueroa JD. Polygenic risk score for the prediction of breast cancer is related to lesser terminal duct lobular unit involution of the breast. NPJ Breast Cancer. 2020 Sep 7; 6 (1):41 Epub 2020 Sept 07
    View PubMed
  11. Dasari S, Pandhiri T, Grassi T, Visscher DW, Multinu F, Agarwal K, Mariani A, Shridhar V, Mitra AK. Signals from the Metastatic Niche Regulate Early and Advanced Ovarian Cancer Metastasis through miR-4454 Downregulation. Mol Cancer Res. 2020 Aug; 18 (8):1202-1217 Epub 2020 Apr 29
    View PubMed
  12. Multinu F, Chen J, Madison JD, Torres M, Casarin J, Visscher D, Shridhar V, Bakkum-Gamez J, Sherman M, Wentzensen N, Mariani A, Walther-Antonio M. Analysis of DNA methylation in endometrial biopsies to predict risk of endometrial cancer. Gynecol Oncol. 2020 Mar; 156 (3):682-688 Epub 2020 Jan 03
    View PubMed
  13. Norton N, Youssef B, Hillman DW, Nassar A, Geiger XJ, Necela BM, Liu H, Ruddy KJ, Polley MC, Ingle JN, Couch FJ, Perez EA, Liu MC, Carter JM, Leon-Ferre RA, Boughey JC, Somers EB, Kalari KR, Visscher DW, Goetz MP, Knutson KL. Folate receptor alpha expression associates with improved disease-free survival in triple negative breast cancer patients. NPJ Breast Cancer. 2020 Feb 4; 6 (1):4 Epub 2020 Feb 04
    View PubMed
  14. Adhikary S, Hoskin TL, Stallings-Mann ML, Arshad M, Frost MH, Winham SJ, Pena A, Lee DJ, Murphy LM, Rakoff M, Denison LA, Knutson KL, Radisky DC, Visscher DW, Degnim AC. Cytotoxic T cell depletion with increasing epithelial abnormality in women with benign breast disease. Breast Cancer Res Treat. 2020 Feb; 180 (1):55-61 Epub 2020 Jan 13
    View PubMed
  15. Norton N, Youssef B, Hillman DW, Nassar A, Geiger XJ, Necela BM, Liu H, Ruddy KJ, Polley MC, Ingle JN, Couch FJ, Perez EA, Liu MC, Carter JM, Leon-Ferre RA, Boughey JC, Somers EB, Kalari KR, Visscher DW, Goetz MP, Knutson KL. Folate receptor alpha expression associates with improved disease-free survival in triple negative breast cancer patients. NPJ Breast Cancer. 2020; 6:4 Epub 2020 Feb 04
    View PubMed
  16. Bodelon C, Oh H, Derkach A, Sampson JN, Sprague BL, Vacek P, Weaver DL, Fan S, Palakal M, Papathomas D, Xiang J, Patel DA, Linville L, Clare SE, Visscher DW, Mies C, Hewitt SM, Brinton LA, Storniolo AMV, He C, Chanock SJ, Garcia-Closas M, Gierach GL, Figueroa JD. Polygenic risk score for the prediction of breast cancer is related to lesser terminal duct lobular unit involution of the breast. NPJ Breast Cancer. 2020; 6:41 Epub 2020 Sept 07
    View PubMed
  17. Solanki M, Visscher D. Pathology of breast cancer in the last half century. Hum Pathol. 2020 Jan; 95:137-148 Epub 2019 Nov 01
    View PubMed
  18. Mariani A, Wang C, Oberg AL, Riska SM, Torres M, Kumka J, Multinu F, Sagar G, Roy D, Jung DB, Zhang Q, Grassi T, Visscher DW, Patel VP, Jin L, Staub JK, Cliby WA, Weroha SJ, Kalli KR, Hartmann LC, Kaufmann SH, Goode EL, Shridhar V. Genes associated with bowel metastases in ovarian cancer. Gynecol Oncol. 2019 Sep; 154 (3):495-504 Epub 2019 June 14
    View PubMed
  19. Lee HE, Arshad M, Brahmbhatt RD, Hoskin TL, Winham SJ, Frost MH, Radisky DC, Denison LA, Degnim AC, Visscher DW. Hyaline fibrous involution of breast lobules: a histologic finding associated with germline BRCA mutation. Mod Pathol. 2019 Sep; 32 (9):1263-1270 Epub 2019 Apr 17
    View PubMed
  20. Al-Hilli Z, Choong G, Keeney MG, Visscher DW, Ingle JN, Goetz MP, Jakub JW. Metaplastic breast cancer has a poor response to neoadjuvant systemic therapy. Breast Cancer Res Treat. 2019 Aug; 176 (3):709-716 Epub 2019 May 22
    View PubMed
  21. Moyer AM, Yu J, Sinnwell JP, Dockter TJ, Suman VJ, Weinshilboum RM, Boughey JC, Goetz MP, Visscher DW, Wang L. Spontaneous murine tumors in the development of patient-derived xenografts: a potential pitfall. Oncotarget. 2019 Jun 11; 10 (39):3924-3930 Epub 2019 June 11
    View PubMed
  22. Shieh Y, Scott CG, Jensen MR, Norman AD, Bertrand KA, Pankratz VS, Brandt KR, Visscher DW, Shepherd JA, Tamimi RM, Vachon CM, Kerlikowske K. Body mass index, mammographic density, and breast cancer risk by estrogen receptor subtype. Breast Cancer Res. 2019 Apr 03; 21(1):48.
    View PubMed
  23. Hurley RM, Wahner Hendrickson AE, Visscher DW, Ansell P, Harrell MI, Wagner JM, Negron V, Goergen KM, Maurer MJ, Oberg AL, Meng XW, Flatten KS, De Jonge MJA, Van Herpen CD, Gietema JA, Koornstra RHT, Jager A, den Hollander MW, Dudley M, Shepherd SP, Swisher EM, Kaufmann SH. 53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer. Gynecol Oncol. 2019 Apr; 153 (1):127-134 Epub 2019 Jan 25
    View PubMed
  24. Fang H, Langstraat CL, Visscher DW, Folpe AL, Schoolmeester JK. Epithelioid Inflammatory Myofibroblastic Sarcoma of the Ovary With RANB2-ALK Fusion: Report of a Case. Int J Gynecol Pathol. 2018 Sep; 37 (5):468-472
    View PubMed
  25. Shaik AN, Ruterbusch JJ, Abdulfatah E, Shrestha R, Daaboul MHDF, Pardeshi V, Visscher DW, Bandyopadhyay S, Ali-Fehmi R, Cote ML. Breast fibroadenomas are not associated with increased breast cancer risk in an African American contemporary cohort of women with benign breast disease. Breast Cancer Res. 2018 Aug 9; 20 (1):91 Epub 2018 Aug 09
    View PubMed
  26. Frank RD, Winham SJ, Vierkant RA, Frost MH, Radisky DC, Ghosh K, Brandt KR, Sherman ME, Visscher DW, Hartmann LC, Degnim AC, Vachon CM. Evaluation of 2 breast cancer risk models in a benign breast disease cohort. Cancer. 2018 Aug; 124 (16):3319-3328 Epub 2018 June 22
    View PubMed
  27. Yasir S, Nassar A, Jimenez RE, Jenkins SM, Hartmann LC, Degnim AC, Frost M, Visscher DW. Cellular fibroepithelial lesions of the breast: A long term follow up study. Ann Diagn Pathol. 2018 Aug; 35:85-91 Epub 2018 Jan 10
    View PubMed
  28. Kalli KR, Block MS, Kasi PM, Erskine CL, Hobday TJ, Dietz A, Padley D, Gustafson MP, Shreeder B, Puglisi-Knutson D, Visscher DW, Mangskau TK, Wilson G, Knutson KL. Folate Receptor Alpha Peptide Vaccine Generates Immunity in Breast and Ovarian Cancer Patients. Clin Cancer Res. 2018 Jul 1; 24 (13):3014-3025 Epub 2018 Mar 15
    View PubMed
  29. Rice MS, Tamimi RM, Bertrand KA, Scott CG, Jensen MR, Norman AD, Visscher DW, Chen YY, Brandt KR, Couch FJ, Shepherd JA, Fan B, Wu FF, Ma L, Collins LC, Cummings SR, Kerlikowske K, Vachon CM. Does mammographic density mediate risk factor associations with breast cancer? An analysis by tumor characteristics. Breast Cancer Res Treat. 2018 Jul; 170(1):129-141. Epub 2018 Mar 03.
    View PubMed
  30. Degnim AC, Winham SJ, Frank RD, Pankratz VS, Dupont WD, Vierkant RA, Frost MH, Hoskin TL, Vachon CM, Ghosh K, Hieken TJ, Carter JM, Denison LA, Broderick B, Hartmann LC, Visscher DW, Radisky DC. Model for Predicting Breast Cancer Risk in Women With Atypical Hyperplasia. J Clin Oncol. 2018 Jun 20; 36 (18):1840-1846 Epub 2018 Apr 20
    View PubMed
  31. Yu J, Qin B, Moyer AM, Nowsheen S, Liu T, Qin S, Zhuang Y, Liu D, Lu SW, Kalari KR, Visscher DW, Copland JA, McLaughlin SA, Moreno-Aspitia A, Northfelt DW, Gray RJ, Lou Z, Suman VJ, Weinshilboum R, Boughey JC, Goetz MP, Wang L. DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine. J Clin Invest. 2018 Jun 1; 128 (6):2376-2388 Epub 2018 Apr 30
    View PubMed
  32. Kerekes D, Visscher DW, Hoskin TL, Radisky DC, Brahmbhatt RD, Pena A, Frost MH, Arshad M, Stallings-Mann M, Winham SJ, Murphy L, Denison L, Carter JM, Knutson KL, Degnim AC. CD56+ immune cell infiltration and MICA are decreased in breast lobules with fibrocystic changes. Breast Cancer Res Treat. 2018 Feb; 167 (3):649-658 Epub 2017 Nov 01
    View PubMed
  33. Carter JM, Hoskin TL, Pena MA, Brahmbhatt R, Winham SJ, Frost MH, Stallings-Mann M, Radisky DC, Knutson KL, Visscher DW, Degnim AC. Macrophagic "Crown-like Structures" Are Associated with an Increased Risk of Breast Cancer in Benign Breast Disease. Cancer Prev Res (Phila). 2018 Feb; 11 (2):113-119 Epub 2017 Nov 22
    View PubMed
  34. Shen J, Hu Y, Putt KS, Singhal S, Han H, Visscher DW, Murphy LM, Low PS. Assessment of folate receptor alpha and beta expression in selection of lung and pancreatic cancer patients for receptor targeted therapies. Oncotarget. 2018 Jan 12; 9 (4):4485-4495 Epub 2017 Dec 15
    View PubMed
  35. Leon-Ferre RA, Polley MY, Liu H, Gilbert JA, Cafourek V, Hillman DW, Elkhanany A, Akinhanmi M, Lilyquist J, Thomas A, Negron V, Boughey JC, Liu MC, Ingle JN, Kalari KR, Couch FJ, Visscher DW, Goetz MP. Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer. Breast Cancer Res Treat. 2018 Jan; 167 (1):89-99 Epub 2017 Sept 14
    View PubMed
  36. Al-Hilli Z, Javed A, Boughey JC, Lemaine V, Visscher DW, Pruthi S. Breast cysts rapidly enlarging with replacement of breast parenchyma and asymmetry. Breast J. 2018 Jan; 24 (1):83-85 Epub 2017 June 07
    View PubMed
  37. Ghosh K, Vierkant RA, Frank RD, Winham S, Visscher DW, Pankratz VS, Scott CG, Brandt K, Sherman ME, Radisky DC, Frost MH, Hartmann LC, Degnim AC, Vachon CM. Association between mammographic breast density and histologic features of benign breast disease. Breast Cancer Res. 2017 Dec 19; 19 (1):134
    View PubMed
  38. Yu J, Qin B, Moyer AM, Sinnwell JP, Thompson KJ, Copland JA 3rd, Marlow LA, Miller JL, Yin P, Gao B, Minter-Dykhouse K, Tang X, McLaughlin SA, Moreno-Aspitia A, Schweitzer A, Lu Y, Hubbard J, Northfelt DW, Gray RJ, Hunt K, Conners AL, Suman VJ, Kalari KR, Ingle JN, Lou Z, Visscher DW, Weinshilboum R, Boughey JC, Goetz MP, Wang L. Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study. Breast Cancer Res. 2017 Dec 6; 19 (1):130 Epub 2017 Dec 06
    View PubMed
  39. Stallings-Mann ML, Heinzen EP, Vierkant RA, Winham SJ, Hoskin TL, Denison LA, Nassar A, Hartmann LC, Visscher DW, Frost MH, Sherman ME, Degnim AC, Radisky DC. Postlactational involution biomarkers plasminogen and phospho-STAT3 are linked with active age-related lobular involution. Breast Cancer Res Treat. 2017 Nov; 166 (1):133-143 Epub 2017 July 27
    View PubMed
  40. Winham SJ, Mehner C, Heinzen EP, Broderick BT, Stallings-Mann M, Nassar A, Vierkant RA, Hoskin TL, Frank RD, Wang C, Denison LA, Vachon CM, Frost MH, Hartmann LC, Aubrey Thompson E, Sherman ME, Visscher DW, Degnim AC, Radisky DC. NanoString-based breast cancer risk prediction for women with sclerosing adenosis. Breast Cancer Res Treat. 2017 Nov; 166 (2):641-650 Epub 2017 Aug 10
    View PubMed
  41. Goetz MP, Suman VJ, Reid JM, Northfelt DW, Mahr MA, Ralya AT, Kuffel M, Buhrow SA, Safgren SL, McGovern RM, Black J, Dockter T, Haddad T, Erlichman C, Adjei AA, Visscher D, Chalmers ZR, Frampton G, Kipp BR, Liu MC, Hawse JR, Doroshow JH, Collins JM, Streicher H, Ames MM, Ingle JN. First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer. J Clin Oncol. 2017 Oct 20; 35(30):3391-3400. Epub 2017 Aug 30.
    View PubMed
  42. Visscher DW, Frank RD, Carter JM, Vierkant RA, Winham SJ, Heinzen EP, Broderick BT, Denison LA, Allers TM, Johnson JL, Frost MH, Hartmann LC, Degnim AC, Radisky DC. Breast Cancer Risk and Progressive Histology in Serial Benign Biopsies. J Natl Cancer Inst. 2017 Oct 01; 109(10).
    View PubMed
  43. Yaghjyan L, Tamimi RM, Bertrand KA, Scott CG, Jensen MR, Pankratz VS, Brandt K, Visscher D, Norman A, Couch F, Shepherd J, Fan B, Chen YY, Ma L, Beck AH, Cummings SR, Kerlikowske K, Vachon CM. Interaction of mammographic breast density with menopausal status and postmenopausal hormone use in relation to the risk of aggressive breast cancer subtypes. Breast Cancer Res Treat. 2017 Sep; 165 (2):421-431 Epub 2017 June 17
    View PubMed
  44. Olsen DL, Keeney GL, Chen B, Visscher DW, Carter JM. Breast implant capsule-associated squamous cell carcinoma: a report of 2 cases. Hum Pathol. 2017 Sep; 67:94-100 Epub 2017 July 22
    View PubMed
  45. Yaghjyan L, Stoll E, Ghosh K, Scott CG, Jensen MR, Brandt KR, Visscher D, Vachon CM. Tissue-based associations of mammographic breast density with breast stem cell markers. Breast Cancer Res. 2017 Aug 29; 19 (1):100
    View PubMed
  46. Butler KA, Hou X, Becker MA, Zanfagnin V, Enderica-Gonzalez S, Visscher D, Kalli KR, Tienchaianada P, Haluska P, Weroha SJ. Prevention of Human Lymphoproliferative Tumor Formation in Ovarian Cancer Patient-Derived Xenografts. Neoplasia. 2017 Aug; 19(8):628-636. Epub 2017 Jun 26.
    View PubMed
  47. Degnim AC, Hoskin TL, Arshad M, Frost MH, Winham SJ, Brahmbhatt RA, Pena A, Carter JM, Stallings-Mann ML, Murphy LM, Miller EE, Denison LA, Vachon CM, Knutson KL, Radisky DC, Visscher DW. Alterations in the Immune Cell Composition in Premalignant Breast Tissue that Precede Breast Cancer Development. Clin Cancer Res. 2017 Jul 15; 23 (14):3945-3952 Epub 2017 Jan 26
    View PubMed
  48. Pena A, Shah SS, Fazzio RT, Hoskin TL, Brahmbhatt RD, Hieken TJ, Jakub JW, Boughey JC, Visscher DW, Degnim AC. Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia. Breast Cancer Res Treat. 2017 Jul; 164 (2):295-304 Epub 2017 May 04
    View PubMed
  49. Goetz MP, Kalari KR, Suman VJ, Moyer AM, Yu J, Visscher DW, Dockter TJ, Vedell PT, Sinnwell JP, Tang X, Thompson KJ, McLaughlin SA, Moreno-Aspitia A, Copland JA, Northfelt DW, Gray RJ, Hunt K, Conners A, Sicotte H, Eckel-Passow JE, Kocher JP, Ingle JN, Ellingson MS, McDonough M, Wieben ED, Weinshilboum R, Wang L, Boughey JC. Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer. J Natl Cancer Inst. 2017 Jul 1; 109 (7)
    View PubMed
  50. Keeney MG, Couch FJ, Visscher DW, Lindor NM. Non-BRCA familial breast cancer: review of reported pathology and molecular findings. Pathology. 2017 Jun; 49 (4):363-370 Epub 2017 Apr 24
    View PubMed
  51. Visscher DW, Yasir S. Neuroendocrine Tumors of the Breast. Endocr Pathol. 2017 Jun; 28 (2):121-127
    View PubMed
  52. Bodelon C, Oh H, Chatterjee N, Garcia-Closas M, Palakal M, Sherman ME, Pfeiffer RM, Geller B, Vacek P, Weaver DL, Chicoine R, Papathomas D, Xiang J, Patel DA, Khodr ZG, Linville L, Clare SE, Visscher DW, Mies C, Hewitt SM, Brinton LA, Storniolo AMV, He C, Chanock SJ, Gierach GL, Figueroa JD. Association between breast cancer genetic susceptibility variants and terminal duct lobular unit involution of the breast. Int J Cancer. 2017 Feb 15; 140 (4):825-832 Epub 2016 Nov 18
    View PubMed
  53. Vierkant RA, Degnim AC, Radisky DC, Visscher DW, Heinzen EP, Frank RD, Winham SJ, Frost MH, Scott CG, Jensen MR, Ghosh K, Manduca A, Brandt KR, Whaley DH, Hartmann LC, Vachon CM. Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort. BMC Cancer. 2017 Jan 31; 17 (1):84
    View PubMed
  54. Mullooly M, Yang HP, Falk RT, Nyante SJ, Cora R, Pfeiffer RM, Radisky DC, Visscher DW, Hartmann LC, Carter JM, Degnim AC, Stanczyk FZ, Figueroa JD, Garcia-Closas M, Lissowska J, Troester MA, Hewitt SM, Brinton LA, Sherman ME, Gierach GL. Relationship between crown-like structures and sex-steroid hormones in breast adipose tissue and serum among postmenopausal breast cancer patients. Breast Cancer Res. 2017 Jan 19; 19 (1):8
    View PubMed
  55. Rangan A, Visscher DW. Mott cell (Russell body) Barrett's esophagitis. Blood. 2016 Oct 13; 128 (15):1992
    View PubMed
  56. Li Z, Block MS, Vierkant RA, Fogarty ZC, Winham SJ, Visscher DW, Kalli KR, Wang C, Goode EL. The inflammatory microenvironment in epithelial ovarian cancer: a role for TLR4 and MyD88 and related proteins. Tumour Biol. 2016 Oct; 37: (10)13279-13286.
    View PubMed
  57. Degnim AC, Dupont WD, Radisky DC, Vierkant RA, Frank RD, Frost MH, Winham SJ, Sanders ME, Smith JR, Page DL, Hoskin TL, Vachon CM, Ghosh K, Hieken TJ, Denison LA, Carter JM, Hartmann LC, Visscher DW. Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of women. Cancer. 2016 Oct; 122 (19):2971-8 Epub 2016 June 28
    View PubMed
  58. Figueroa JD, Pfeiffer RM, Brinton LA, Palakal MM, Degnim AC, Radisky D, Hartmann LC, Frost MH, Stallings Mann ML, Papathomas D, Gierach GL, Hewitt SM, Duggan MA, Visscher D, Sherman ME. Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease: a nested case-control study. Breast Cancer Res Treat. 2016 Aug; 159 (1):163-72 Epub 2016 Aug 03
    View PubMed
  59. Oh H, Bodelon C, Palakal M, Chatterjee N, Sherman ME, Linville L, Geller BM, Vacek PM, Weaver DL, Chicoine RE, Papathomas D, Patel DA, Xiang J, Clare SE, Visscher DW, Mies C, Hewitt SM, Brinton LA, Storniolo AM, He C, Garcia-Closas M, Chanock SJ, Gierach GL, Figueroa JD. Ages at menarche- and menopause-related genetic variants in relation to terminal duct lobular unit involution in normal breast tissue. Breast Cancer Res Treat. 2016 Jul; 158 (2):341-50 Epub 2016 June 24
    View PubMed
  60. Purrington KS, Visscher DW, Wang C, Yannoukakos D, Hamann U, Nevanlinna H, Cox A, Giles GG, Eckel-Passow JE, Lakis S, Kotoula V, Fountzilas G, Kabisch M, Rudiger T, Heikkila P, Blomqvist C, Cross SS, Southey MC, Olson JE, Gilbert J, Deming-Halverson S, Kosma VM, Clarke C, Scott R, Jones JL, Zheng W, Mannermaa A, Eccles DM, Vachon CM, Couch FJ, Jane Carpenter for ABCTC Investigators. Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes. Breast Cancer Res Treat. 2016 May; 157 (1):117-31 Epub 2016 Apr 15
    View PubMed
  61. Meares AL, Frank RD, Degnim AC, Vierkant RA, Frost MH, Hartmann LC, Winham SJ, Visscher DW. Mucocele-like lesions of the breast: a clinical outcome and histologic analysis of 102 cases. Hum Pathol. 2016 Mar; 49:33-8 Epub 2015 Oct 31
    View PubMed
  62. Yoon HH, Foster NR, Meyers JP, Steen PD, Visscher DW, Pillai R, Prow DM, Reynolds CM, Marchello BT, Mowat RB, Mattar BI, Erlichman C, Goetz MP. Gene expression profiling identifies responsive patients with cancer of unknown primary treated with carboplatin, paclitaxel, and everolimus: NCCTG N0871 (alliance). Ann Oncol. 2016 Feb; 27 (2):339-44 Epub 2015 Nov 16
    View PubMed
  63. Radisky DC, Visscher DW, Frank RD, Vierkant RA, Winham S, Stallings-Mann M, Hoskin TL, Nassar A, Vachon CM, Denison LA, Hartmann LC, Frost MH, Degnim AC. Natural history of age-related lobular involution and impact on breast cancer risk. Breast Cancer Res Treat. 2016 Feb; 155 (3):423-30 Epub 2016 Feb 04
    View PubMed
  64. Visscher DW, Frost MH, Hartmann LC, Frank RD, Vierkant RA, McCullough AE, Winham SJ, Vachon CM, Ghosh K, Brandt KR, Farrell AM, Tarabishy Y, Hieken TJ, Haddad TC, Kraft RA, Radisky DC, Degnim AC. Clinicopathologic features of breast cancers that develop in women with previous benign breast disease. Cancer. 2016 Feb 1; 122 (3):378-85 Epub 2015 Oct 29
    View PubMed
  65. Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, Suman VJ, Johnson J, Blake C, Tlsty T, Vachon CM, Melton LJ, Visscher DW. Benign breast disease and the risk of breast cancer Obstetrical and Gynecological Survey. 2016; 71: (8)472-3.
  66. Hieken TJ, Carter JM, Hawse JR, Hoskin TL, Bois M, Frost M, Hartmann LC, Radisky DC, Visscher DW, Degnim AC. ERbeta expression and breast cancer risk prediction for women with atypias. Cancer Prev Res (Phila). 2015 Nov; 8 (11):1084-92 Epub 2015 Aug 14
    View PubMed
  67. Ellingson MS, Hart SN, Kalari KR, Suman V, Schahl KA, Dockter TJ, Felten SJ, Sinnwell JP, Thompson KJ, Tang X, Vedell PT, Barman P, Sicotte H, Eckel-Passow JE, Northfelt DW, Gray RJ, McLaughlin SA, Moreno-Aspitia A, Ingle JN, Moyer AM, Visscher DW, Jones K, Conners A, McDonough M, Wieben ED, Wang L, Weinshilboum R, Boughey JC, Goetz MP. Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy. Breast Cancer Res Treat. 2015 Sep; 153 (2):435-43 Epub 2015 Aug 22
    View PubMed
  68. Nassar A, Visscher DW, Degnim AC, Frank RD, Vierkant RA, Frost M, Radisky DC, Vachon CM, Kraft RA, Hartmann LC, Ghosh K. Complex fibroadenoma and breast cancer risk: a Mayo Clinic Benign Breast Disease Cohort Study. Breast Cancer Res Treat. 2015 Sep; 153 (2):397-405 Epub 2015 Aug 12
    View PubMed
  69. Degnim AC, Nassar A, Stallings-Mann M, Keith Anderson S, Oberg AL, Vierkant RA, Frank RD, Wang C, Winham SJ, Frost MH, Hartmann LC, Visscher DW, Radisky DC. Gene signature model for breast cancer risk prediction for women with sclerosing adenosis. Breast Cancer Res Treat. 2015 Aug; 152 (3):687-94 Epub 2015 July 23
    View PubMed
  70. Sobral-Leite M, Wesseling J, Smit VT, Nevanlinna H, van Miltenburg MH, Sanders J, Hofland I, Blows FM, Coulson P, Patrycja G, Schellens JH, Fagerholm R, Heikkila P, Aittomaki K, Blomqvist C, Provenzano E, Ali HR, Figueroa J, Sherman M, Lissowska J, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Phillips KA, Couch FJ, Olson JE, Vachon C, Visscher D, Brenner H, Butterbach K, Arndt V, Holleczek B, Hooning MJ, Hollestelle A, Martens JW, van Deurzen CH, van de Water B, Broeks A, Chang-Claude J, Chenevix-Trench G, Easton DF, Pharoah PD, Garcia-Closas M, de Graauw M, Schmidt MK, kConFab/AOCS Investigators. Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis. BMC Med. 2015 Jul 2; 13:156 Epub 2015 July 02
    View PubMed
  71. Said SM, Visscher DW, Nassar A, Frank RD, Vierkant RA, Frost MH, Ghosh K, Radisky DC, Hartmann LC, Degnim AC. Flat epithelial atypia and risk of breast cancer: A Mayo cohort study. Cancer. 2015 May 15; 121 (10):1548-55 Epub 2015 Jan 13
    View PubMed
  72. Geels YP, van der Putten LJ, van Tilborg AA, Lurkin I, Zwarthoff EC, Pijnenborg JM, van den Berg-van Erp SH, Snijders MP, Bulten J, Visscher DW, Dowdy SC, Massuger LF. Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium. Gynecol Oncol. 2015 May; 137(2):245-51. Epub 2015 Mar 12.
    View PubMed
  73. Nassar A, Hoskin TL, Stallings-Mann ML, Degnim AC, Radisky DC, Frost MH, Vierkant RA, Hartmann LC, Visscher DW. Ki-67 expression in sclerosing adenosis and adjacent normal breast terminal ductal lobular units: a nested case-control study from the Mayo Benign Breast Disease Cohort. Breast Cancer Res Treat. 2015 May; 151 (1):89-97 Epub 2015 Apr 12
    View PubMed
  74. Bertrand KA, Scott CG, Tamimi RM, Jensen MR, Pankratz VS, Norman AD, Visscher DW, Couch FJ, Shepherd J, Chen YY, Fan B, Wu FF, Ma L, Beck AH, Cummings SR, Kerlikowske K, Vachon CM. Dense and nondense mammographic area and risk of breast cancer by age and tumor characteristics. Cancer Epidemiol Biomarkers Prev. 2015 May; 24(5):798-809. Epub 2015 Feb 25.
    View PubMed
  75. Wahner Hendrickson AE, Hawthorne KM, Goode EL, Kalli KR, Goergen KM, Bakkum-Gamez JN, Cliby WA, Keeney GL, Visscher DW, Tarabishy Y, Oberg AL, Hartmann LC, Maurer MJ. Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo Clinic. Gynecol Oncol. 2015 Apr; 137 (1):77-85 Epub 2015 Jan 22
    View PubMed
  76. Pankratz VS, Degnim AC, Frank RD, Frost MH, Visscher DW, Vierkant RA, Hieken TJ, Ghosh K, Tarabishy Y, Vachon CM, Radisky DC, Hartmann LC. Model for individualized prediction of breast cancer risk after a benign breast biopsy. J Clin Oncol. 2015 Mar 10; 33 (8):923-9 Epub 2015 Jan 26
    View PubMed
  77. Howat WJ, Blows FM, Provenzano E, Brook MN, Morris L, Gazinska P, Johnson N, McDuffus LA, Miller J, Sawyer EJ, Pinder S, van Deurzen CH, Jones L, Sironen R, Visscher D, Caldas C, Daley F, Coulson P, Broeks A, Sanders J, Wesseling J, Nevanlinna H, Fagerholm R, Blomqvist C, Heikkila P, Ali HR, Dawson SJ, Figueroa J, Lissowska J, Brinton L, Mannermaa A, Kataja V, Kosma VM, Cox A, Brock IW, Cross SS, Reed MW, Couch FJ, Olson JE, Devillee P, Mesker WE, Seyaneve CM, Hollestelle A, Benitez J, Perez JI, Menendez P, Bolla MK, Easton DF, Schmidt MK, Pharoah PD, Sherman ME, Garcia-Closas M. Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium. J Pathol Clin Res. 2015 Jan; 1 (1):18-32 Epub 2014 Dec 04
    View PubMed
  78. Mansfield AS, Visscher DW, Hart SN, Wang C, Goetz MP, Oxvig C, Conover CA. Pregnancy-associated plasma protein-A expression in human breast cancer. Growth Horm IGF Res. 2014 Dec; 24(6):264-7.
    View PubMed
  79. Khodr ZG, Sherman ME, Pfeiffer RM, Gierach GL, Brinton LA, Falk RT, Patel DA, Linville LM, Papathomas D, Clare SE, Visscher DW, Mies C, Hewitt SM, Storniolo AM, Rosebrock A, Caban JJ, Figueroa JD. Circulating sex hormones and terminal duct lobular unit involution of the normal breast. Cancer Epidemiol Biomarkers Prev. 2014 Dec; 23 (12):2765-73
    View PubMed
  80. Jorns JM, Thomas DG, Healy PN, Daignault S, Vickery TL, Snider JE, Mardis ER, Davies SR, Ellis MJ, Visscher DW. Estrogen receptor expression is high but is of lower intensity in tubular carcinoma than in well-differentiated invasive ductal carcinoma. Arch Pathol Lab Med. 2014 Nov; 138 (11):1507-13
    View PubMed
  81. Figueroa JD, Pfeiffer RM, Patel DA, Linville L, Brinton LA, Gierach GL, Yang XR, Papathomas D, Visscher D, Mies C, Degnim AC, Anderson WF, Hewitt S, Khodr ZG, Clare SE, Storniolo AM, Sherman ME. Terminal duct lobular unit involution of the normal breast: implications for breast cancer etiology. J Natl Cancer Inst. 2014 Oct; 106 (10) Epub 2014 Oct 01
    View PubMed
  82. Yasir S, Gamez R, Jenkins S, Visscher DW, Nassar A. Significant histologic features differentiating cellular fibroadenoma from phyllodes tumor on core needle biopsy specimens. Am J Clin Pathol. 2014 Sep; 142 (3):362-9
    View PubMed
  83. Wang C, Cicek MS, Charbonneau B, Kalli KR, Armasu SM, Larson MC, Konecny GE, Winterhoff B, Fan JB, Bibikova M, Chien J, Shridhar V, Block MS, Hartmann LC, Visscher DW, Cunningham JM, Knutson KL, Fridley BL, Goode EL. Tumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancer. Cancer Res. 2014 Jun 1; 74 (11):3084-91 Epub 2014 Apr 11
    View PubMed
  84. Purrington KS, Slager S, Eccles D, Yannoukakos D, Fasching PA, Miron P, Carpenter J, Chang-Claude J, Martin NG, Montgomery GW, Kristensen V, Anton-Culver H, Goodfellow P, Tapper WJ, Rafiq S, Gerty SM, Durcan L, Konstantopoulou I, Fostira F, Vratimos A, Apostolou P, Konstanta I, Kotoula V, Lakis S, Dimopoulos MA, Skarlos D, Pectasides D, Fountzilas G, Beckmann MW, Hein A, Ruebner M, Ekici AB, Hartmann A, Schulz-Wendtland R, Renner SP, Janni W, Rack B, Scholz C, Neugebauer J, Andergassen U, Lux MP, Haeberle L, Clarke C, Pathmanathan N, Rudolph A, Flesch-Janys D, Nickels S, Olson JE, Ingle JN, Olswold C, Slettedahl S, Eckel-Passow JE, Anderson SK, Visscher DW, Cafourek VL, Sicotte H, Prodduturi N, Weiderpass E, Bernstein L, Ziogas A, Ivanovich J, Giles GG, Baglietto L, Southey M, Kosma VM, Fischer HP, Reed MW, Cross SS, Deming-Halverson S, Shrubsole M, Cai Q, Shu XO, Daly M, Weaver J, Ross E, Klemp J, Sharma P, Torres D, Rudiger T, Wolfing H, Ulmer HU, Forsti A, Khoury T, Kumar S, Pilarski R, Shapiro CL, Greco D, Heikkila P, Aittomaki K, Blomqvist C, Irwanto A, Liu J, Pankratz VS, Wang X, Severi G, Mannermaa A, Easton D, Hall P, Brauch H, Cox A, Zheng W, Godwin AK, Hamann U, Ambrosone C, Toland AE, Nevanlinna H, Vachon CM, Couch FJ, GENICA Network. Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer. Carcinogenesis. 2014 May; 35 (5):1012-9 Epub 2013 Dec 09
    View PubMed
  85. Neal L, Sandhu NP, Hieken TJ, Glazebrook KN, Mac Bride MB, Dilaveri CA, Wahner-Roedler DL, Ghosh K, Visscher DW. Diagnosis and management of benign, atypical, and indeterminate breast lesions detected on core needle biopsy. Mayo Clin Proc. 2014 Apr; 89 (4):536-47
    View PubMed
  86. Degnim AC, Brahmbhatt RD, Radisky DC, Hoskin TL, Stallings-Mann M, Laudenschlager M, Mansfield A, Frost MH, Murphy L, Knutson K, Visscher DW. Immune cell quantitation in normal breast tissue lobules with and without lobulitis. Breast Cancer Res Treat. 2014 Apr; 144 (3):539-49 Epub 2014 Mar 05
    View PubMed
  87. Kaur JS, Vierkant RA, Hobday T, Visscher D. Regional differences in breast cancer biomarkers in american Indian and Alaska native women. Cancer Epidemiol Biomarkers Prev. 2014 Mar; 23 (3):409-15
    View PubMed
  88. Hartmann LC, Radisky DC, Frost MH, Santen RJ, Vierkant RA, Benetti LL, Tarabishy Y, Ghosh K, Visscher DW, Degnim AC. Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study. Cancer Prev Res (Phila). 2014 Feb; 7 (2):211-7 Epub 2014 Jan 30
    View PubMed
  89. Visscher DW, Nassar A, Degnim AC, Frost MH, Vierkant RA, Frank RD, Tarabishy Y, Radisky DC, Hartmann LC. Sclerosing adenosis and risk of breast cancer. Breast Cancer Res Treat. 2014 Feb; 144 (1):205-12 Epub 2014 Feb 08
    View PubMed
  90. Bertrand KA, Tamimi RM, Scott CG, Jensen MR, Pankratz V, Visscher D, Norman A, Couch F, Shepherd J, Fan B, Chen YY, Ma L, Beck AH, Cummings SR, Kerlikowske K, Vachon CM. Mammographic density and risk of breast cancer by age and tumor characteristics. Breast Cancer Res. 2013 Nov 4; 15 (6):R104 Epub 2013 Nov 04
    View PubMed
  91. Kobel M, Kalloger SE, Lee S, Duggan MA, Kelemen LE, Prentice L, Kalli KR, Fridley BL, Visscher DW, Keeney GL, Vierkant RA, Cunningham JM, Chow C, Ness RB, Moysich K, Edwards R, Modugno F, Bunker C, Wozniak EL, Benjamin E, Gayther SA, Gentry-Maharaj A, Menon U, Gilks CB, Huntsman DG, Ramus SJ, Goode EL, Ovarian Tumor Tissue Analysis consortium. Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortium. Cancer Epidemiol Biomarkers Prev. 2013 Oct; 22 (10):1677-86 Epub 2013 July 23
    View PubMed
  92. Cicek MS, Koestler DC, Fridley BL, Kalli KR, Armasu SM, Larson MC, Wang C, Winham SJ, Vierkant RA, Rider DN, Block MS, Klotzle B, Konecny G, Winterhoff BJ, Hamidi H, Shridhar V, Fan JB, Visscher DW, Olson JE, Hartmann LC, Bibikova M, Chien J, Cunningham JM, Goode EL. Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel. Hum Mol Genet. 2013 Aug 1; 22 (15):3038-47 Epub 2013 Apr 09
    View PubMed
  93. Swapp RE, Glazebrook KN, Jones KN, Brandts HM, Reynolds C, Visscher DW, Hieken TJ. Management of benign intraductal solitary papilloma diagnosed on core needle biopsy. Ann Surg Oncol. 2013 Jun; 20 (6):1900-5 Epub 2013 Jan 13
    View PubMed
  94. Bhattacharyya S, Saha S, Giri K, Lanza IR, Nair KS, Jennings NB, Rodriguez-Aguayo C, Lopez-Berestein G, Basal E, Weaver AL, Visscher DW, Cliby W, Sood AK, Bhattacharya R, Mukherjee P. Cystathionine beta-synthase (CBS) contributes to advanced ovarian cancer progression and drug resistance. PLoS One. 2013; 8 (11):e79167 Epub 2013 Nov 13
    View PubMed
  95. Preston CC, Maurer MJ, Oberg AL, Visscher DW, Kalli KR, Hartmann LC, Goode EL, Knutson KL. The ratios of CD8+ T cells to CD4+CD25+ FOXP3+ and FOXP3- T cells correlate with poor clinical outcome in human serous ovarian cancer. PLoS One. 2013; 8 (11):e80063 Epub 2013 Nov 14
    View PubMed
  96. Cote ML, Ruterbusch JJ, Alosh B, Bandyopadhyay S, Kim E, Albashiti B, Sharaf Aldeen B, Radisky DC, Frost MH, Visscher DW, Hartmann LC, Nassar WH, Ali-Femhi R. Benign breast disease and the risk of subsequent breast cancer in African American women. Cancer Prev Res (Phila). 2012 Dec; 5(12):1375-80. Epub 2012 Oct 19
    View PubMed
  97. Geels YP, Pijnenborg JM, van den, Bulten J, Visscher DW, Dowdy SC, Massuger LF. Endometrioid endometrial carcinoma with atrophic endometrium and poor prognosis. Obstet Gynecol. 2012 Nov; 120(5):1124-31.
    View PubMed
  98. Jorns JM, Visscher D, Sabel M, Breslin T, Healy P, Daignaut S, Myers JL, Wu AJ. Intraoperative frozen section analysis of margins in breast conserving surgery significantly decreases reoperative rates: one-year experience at an ambulatory surgical center. Am J Clin Pathol. 2012 Nov; 138(5):657-69.
    View PubMed
  99. Gerard B, Sanders MA, Visscher DW, Tait L, Shekhar MP. Lysine 394 is a novel Rad6B-induced ubiquitination site on beta-catenin. Biochim Biophys Acta. 2012 Oct; 1823(10):1686-96. Epub 2012 Jun 15.
    View PubMed
  100. Stallings-Mann ML, Waldmann J, Zhang Y, Miller E, Gauthier ML, Visscher DW, Downey GP, Radisky ES, Fields AP, Radisky DC. Matrix metalloproteinase induction of Rac1b, a key effector of lung cancer progression. Sci Transl Med. 2012 Jul 11; 4 (142):142ra95
    View PubMed
  101. Degnim AC, Visscher DW, Hoskin TL, Frost MH, Vierkant RA, Vachon CM, Shane Pankratz V, Radisky DC, Hartmann LC. Histologic findings in normal breast tissues: comparison to reduction mammaplasty and benign breast disease tissues. Breast Cancer Res Treat. 2012 May; 133 (1):169-77 Epub 2011 Sept 01
    View PubMed
  102. Fuehrer N, Hartmann L, Degnim A, Allers T, Vierkant R, Frost M, Visscher D. Atypical apocrine adenosis of the breast: long-term follow-up in 37 patients. Arch Pathol Lab Med. 2012 Feb; 136 (2):179-82
    View PubMed
  103. Ghosh K, Brandt KR, Reynolds C, Scott CG, Pankratz VS, Riehle DL, Lingle WL, Odogwu T, Radisky DC, Visscher DW, Ingle JN, Hartmann LC, Vachon CM. Tissue composition of mammographically dense and non-dense breast tissue. Breast Cancer Res Treat. 2012 Jan; 131 (1):267-75 Epub 2011 Aug 30
    View PubMed
  104. Perez EA, Suman VJ, Davidson NE, Gralow JR, Kaufman PA, Visscher DW, Chen B, Ingle JN, Dakhil SR, Zujewski J, Moreno-Aspitia A, Pisansky TM, Jenkins RB. Sequential versus concurrent trastuzumab in adjuvant chemotherapy for breast cancer. J Clin Oncol. 2011 Dec 1; 29 (34):4491-7 Epub 2011 Oct 31
    View PubMed
  105. Radisky DC, Santisteban M, Berman HK, Gauthier ML, Frost MH, Reynolds CA, Vierkant RA, Pankratz VS, Visscher DW, Tlsty TD, Hartmann LC. p16(INK4a) expression and breast cancer risk in women with atypical hyperplasia. Cancer Prev Res (Phila). 2011 Dec; 4 (12):1953-60 Epub 2011 Sept 15
    View PubMed
  106. Barr FE, Degnim AC, Hartmann LC, Radisky DC, Boughey JC, Anderson SS, Vierkant RA, Frost MH, Visscher DW, Reynolds C. Estrogen receptor expression in atypical hyperplasia: lack of association with breast cancer. Cancer Prev Res (Phila). 2011 Mar; 4(3):435-44. Epub 2011 Jan 05.
    View PubMed
  107. Visscher DW. Genomics, histopathology, and the tumor microenvironment: new relationship or old friends re-discovered? Breast Cancer Res Treat. 2011 Feb; 125(3):697-8. Epub 2010 May 15.
    View PubMed
  108. Cichon MA, Degnim AC, Visscher DW, Radisky DC. Microenvironmental influences that drive progression from benign breast disease to invasive breast cancer. J Mammary Gland Biol Neoplasia. 2010 Dec; 15 (4):389-97 Epub 2010 Dec 16
    View PubMed
  109. Degnim AC, Frost MH, Radisky DC, Anderson SS, Vierkant RA, Boughey JC, Pankratz VS, Ghosh K, Hartmann LC, Visscher DW. Pseudoangiomatous stromal hyperplasia and breast cancer risk. Ann Surg Oncol. 2010 Dec; 17 (12):3269-77 Epub 2010 June 22
    View PubMed
  110. Ghosh K, Vachon CM, Pankratz VS, Vierkant RA, Anderson SS, Brandt KR, Visscher DW, Reynolds C, Frost MH, Hartmann LC. Independent association of lobular involution and mammographic breast density with breast cancer risk. J Natl Cancer Inst. 2010 Nov 17; 102(22):1716-23. Epub 2010 Oct 29.
    View PubMed
  111. Perez EA, Reinholz MM, Hillman DW, Tenner KS, Schroeder MJ, Davidson NE, Martino S, Sledge GW, Harris LN, Gralow JR, Dueck AC, Ketterling RP, Ingle JN, Lingle WL, Kaufman PA, Visscher DW, Jenkins RB. HER2 and chromosome 17 effect on patient outcome in the N9831 adjuvant trastuzumab trial. J Clin Oncol. 2010 Oct 1; 28 (28):4307-15 Epub 2010 Aug 09
    View PubMed
  112. Santisteban M, Reynolds C, Barr Fritcher EG, Frost MH, Vierkant RA, Anderson SS, Degnim AC, Visscher DW, Pankratz VS, Hartmann LC. Ki67: a time-varying biomarker of risk of breast cancer in atypical hyperplasia. Breast Cancer Res Treat. 2010 Jun; 121(2):431-7. Epub 2009 Sep 23.
    View PubMed
  113. Shekhar MP, Biernat LA, Pernick N, Tait L, Abrams J, Visscher DW. Utility of DNA postreplication repair protein Rad6B in neoadjuvant chemotherapy response. Med Oncol. 2010 Jun; 27(2):466-73. Epub 2009 May 23.
    View PubMed
  114. Ghosh K, Hartmann LC, Reynolds C, Visscher DW, Brandt KR, Vierkant RA, Scott CG, Radisky DC, Sellers TA, Pankratz VS, Vachon CM. Association between mammographic density and age-related lobular involution of the breast. J Clin Oncol. 2010 May 1; 28 (13):2207-12 Epub 2010 Mar 29
    View PubMed
  115. McKian KP, Reynolds CA, Visscher DW, Nassar A, Radisky DC, Vierkant RA, Degnim AC, Boughey JC, Ghosh K, Anderson SS, Minot D, Caudill JL, Vachon CM, Frost MH, Pankratz VS, Hartmann LC. Novel breast tissue feature strongly associated with risk of breast cancer. J Clin Oncol. 2009 Dec 10; 27 (35):5893-8 Epub 2009 Oct 05
    View PubMed
  116. Visscher DW. Apocrine ductal carcinoma in situ involving a sclerosing lesion with adenosis: report of a case. Arch Pathol Lab Med. 2009 Nov; 133(11):1817-21.
    View PubMed
  117. McHugh JB, Visscher DW, Barnes EL. Update on selected salivary gland neoplasms. Arch Pathol Lab Med. 2009 Nov; 133(11):1763-74.
    View PubMed
  118. Visscher DW, Myers JL. New frontiers in pathology. Arch Pathol Lab Med. 2009 Nov; 133(11):1761-2.
    View PubMed
  119. Reinholz MM, Bruzek AK, Visscher DW, Lingle WL, Schroeder MJ, Perez EA, Jenkins RB. Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic response. Lancet Oncol. 2009 Mar; 10 (3):267-77
    View PubMed
  120. Shekhar MP, Tait L, Pauley RJ, Wu GS, Santner SJ, Nangia-Makker P, Shekhar V, Nassar H, Visscher DW, Heppner GH, Miller FR. Comedo-ductal carcinoma in situ: A paradoxical role for programmed cell death. Cancer Biol Ther. 2008 Nov; 7(11):1774-82. Epub 2008 Nov 12.
    View PubMed
  121. Visscher DW, Pankratz VS, Santisteban M, Reynolds C, Ristimaki A, Vierkant RA, Lingle WL, Frost MH, Hartmann LC. Association between cyclooxygenase-2 expression in atypical hyperplasia and risk of breast cancer. J Natl Cancer Inst. 2008 Mar 19; 100(6):421-7. Epub 2008 Mar 11.
    View PubMed
  122. Berg JC, Visscher DW, Vierkant RA, Pankratz VS, Maloney SD, Lewis JT, Frost MH, Ghosh K, Degnim AC, Brandt KR, Vachon CM, Reynolds CA, Hartmann LC. Breast cancer risk in women with radial scars in benign breast biopsies. Breast Cancer Res Treat. 2008 Mar; 108 (2):167-74 Epub 2007 May 22
    View PubMed
  123. Zhang L, Visscher D, Rihal C, Aubry MC. Pulmonary veno-occlusive disease as a primary cause of pulmonary hypertension in a patient with mixed connective tissue disease. Rheumatol Int. 2007 Oct; 27 (12):1163-5 Epub 2007 May 23
    View PubMed
  124. Degnim AC, Visscher DW, Berman HK, Frost MH, Sellers TA, Vierkant RA, Maloney SD, Pankratz VS, de Groen PC, Lingle WL, Ghosh K, Penheiter L, Tlsty T, Melton LJ 3rd, Reynolds CA, Hartmann LC. Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol. 2007 Jul 1; 25(19):2671-7. Epub 2007 Jun 11.
    View PubMed
  125. Goetz MP, Knox SK, Suman VJ, Rae JM, Safgren SL, Ames MM, Visscher DW, Reynolds C, Couch FJ, Lingle WL, Weinshilboum RM, Fritcher EG, Nibbe AM, Desta Z, Nguyen A, Flockhart DA, Perez EA, Ingle JN. The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen. Breast Cancer Res Treat. 2007 Jan; 101(1):113-21. Epub 2006 Nov 18.
    View PubMed
  126. Milanese TR, Hartmann LC, Sellers TA, Frost MH, Vierkant RA, Maloney SD, Pankratz VS, Degnim AC, Vachon CM, Reynolds CA, Thompson RA, Melton LJ, Goode EL, Visscher DW. Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst. 2006 Nov 15; 98 (22):1600-7
    View PubMed
  127. Perez EA, Suman VJ, Davidson NE, Martino S, Kaufman PA, Lingle WL, Flynn PJ, Ingle JN, Visscher D, Jenkins RB. HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial. J Clin Oncol. 2006 Jul 1; 24 (19):3032-8
    View PubMed
  128. Lewis JT, Hartmann LC, Vierkant RA, Maloney SD, Shane Pankratz V, Allers TM, Frost MH, Visscher DW. An analysis of breast cancer risk in women with single, multiple, and atypical papilloma. Am J Surg Pathol. 2006 Jun; 30 (6):665-72
    View PubMed
  129. Visscher DW, Myers JL. Histologic spectrum of idiopathic interstitial pneumonias. Proc Am Thorac Soc. 2006 Jun; 3(4):322-9.
    View PubMed
  130. Kato I, Ren J, Visscher DW, Djuric Z. Nutritional predictors for cellular nipple aspirate fluid: Nutrition and Breast Health Study. Breast Cancer Res Treat. 2006 May; 97(1):33-9. Epub 2005 Nov 30.
    View PubMed
  131. Goetz MP, Suman VJ, Ingle JN, Nibbe AM, Visscher DW, Reynolds CA, Lingle WL, Erlander M, Ma XJ, Sgroi DC, Perez EA, Couch FJ. A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen. Clin Cancer Res. 2006 Apr 1; 12 (7 Pt 1):2080-7
    View PubMed
  132. Nassar H, Qureshi H, Volkanadsay N, Visscher D. Clinicopathologic analysis of solid papillary carcinoma of the breast and associated invasive carcinomas. Am J Surg Pathol. 2006 Apr; 30(4):501-7.
    View PubMed
  133. Visscher DW, Myers JL. Bronchiolitis: the pathologist's perspective. Proc Am Thorac Soc. 2006; 3(1):41-7.
    View PubMed
  134. Goetz MP, Rae JM, Suman VJ, Safgren SL, Ames MM, Visscher DW, Reynolds C, Couch FJ, Lingle WL, Flockhart DA, Desta Z, Perez EA, Ingle JN. Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes. J Clin Oncol. 2005 Dec 20; 23 (36):9312-8
    View PubMed
  135. Perez EA, Suman VJ, Rowland KM, Ingle JN, Salim M, Loprinzi CL, Flynn PJ, Mailliard JA, Kardinal CG, Krook JE, Thrower AR, Visscher DW, Jenkins RB. Two concurrent phase II trials of paclitaxel/carboplatin/trastuzumab (weekly or every-3-week schedule) as first-line therapy in women with HER2-overexpressing metastatic breast cancer: NCCTG study 983252. Clin Breast Cancer. 2005 Dec; 6(5):425-32.
    View PubMed
  136. Romond EH, Perez EA, Bryant J, Suman VJ, Geyer CE, Davidson NE, Tan-Chiu E, Martino S, Paik S, Kaufman PA, Swain SM, Pisansky TM, Fehrenbacher L, Kutteh LA, Vogel VG, Visscher DW, Yothers G, Jenkins RB, Brown AM, Dakhil SR, Mamounas EP, Lingle WL, Klein PM, Ingle JN, Wolmark N. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med. 2005 Oct 20; 353(16):1673-84.
    View PubMed
  137. Lewis JT, Ketterling RP, Halling KC, Reynolds C, Jenkins RB, Visscher DW. Analysis of intratumoral heterogeneity and amplification status in breast carcinomas with equivocal (2+) HER-2 immunostaining. Am J Clin Pathol. 2005 Aug; 124 (2):273-81
    View PubMed
  138. Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, Suman VJ, Johnson J, Blake C, Tlsty T, Vachon CM, Melton LJ 3rd, Visscher DW. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005 Jul 21; 353 (3):229-37
    View PubMed
  139. Djuric Z, Visscher DW, Heilbrun LK, Chen G, Atkins M, Covington CY. Influence of lactation history on breast nipple aspirate fluid yields and fluid composition. The Breast Journal. 2005; 11(2):92-99.
    View PubMed
  140. Andea AA, Visscher DW. Staging considerations and behavior of multifocal/multicentric breast carcinomas. The American Journal of Oncology Review.. 2004 Oct 15; 25-30.
  141. Miller DV, Leontovich AA, Lingle WL, Suman VJ, Mertens ML, Lillie J, Ingalls KA, Perez EA, Ingle JN, Couch FJ, Visscher DW. Utilizing Nottingham Prognostic Index in microarray gene expression profiling of breast carcinomas. Mod Pathol. 2004 Jul; 17 (7):756-64
    View PubMed
  142. Nagao T, Gaffey TA, Visscher DW, Kay PA, Minato H, Serizawa H, Lewis JE. Invasive micropapillary salivary duct carcinoma: a distinct histologic variant with biologic significance. Am J Surg Pathol. 2004 Mar; 28 (3):319-26
    View PubMed
  143. Andea AA, Bouwman D, Wallis T, Visscher DW. Correlation of tumor volume and surface area with lymph node status in patients with multifocal/multicentric breast carcinoma. Cancer. 2004 Jan 1; 100(1):20-7.
    View PubMed
  144. Newman LA, Pernick NL, Adsay V, Carolin KA, Philip PA, Sipierski S, Bouwman DL, Kosir MA, White M, Visscher DW. Histopathologic evidence of tumor regression in the axillary lymph nodes of patients treated with preoperative chemotherapy correlates with breast cancer outcome. Ann Surg Oncol. 2003 Aug; 10(7):734-9.
    View PubMed
  145. Adsay NV, Merati K, Nassar H, Shia J, Sarkar F, Pierson CR, Cheng JD, Visscher DW, Hruban RH, Klimstra DS. Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs - Coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of colloid carcinoma in the breast and pancreas. Am J Surg Pathol. 2003 May; 27(5):571-8.
    View PubMed
  146. El-Rayes BF, Ali S, Heilbrun LK, Lababidi S, Bouwman D, Visscher D, Philip PA. Cytochrome p450 and glutathione transferase expression in human breast cancer. Clin Cancer Res. 2003 May; 9(5):1705-9.
    View PubMed
  147. Ali-Fehmi R, Carolin K, Wallis T, Visscher DW. Clinicopathologic analysis of breast lesions associated with multiple papillomas. Hum Pathol. 2003 Mar; 34(3):234-9.
    View PubMed
  148. Bonnett M, Wallis T, Rossmann M, Pernick NL, Bouwman D, Carolin KA, Visscher D. Histopathologic analysis of atypical lesions in image-guided core breast biopsies. Mod Pathol. 2003 Feb; 16(2):154-60.
    View PubMed
  149. Shekhar MP, Lyakhovich A, Visscher DW, Heng H, Kondrat N. Rad6 overexpression induces multinucleation, centrosome amplification, abnormal mitosis, aneuploidy, and transformation. Cancer Res. 2002 Apr 1; 62(7):2115-24.
    View PubMed
  150. Andea AA, Wallis T, Newman LA, Bouwman D, Dey J, Visscher DW. Pathologic analysis of tumor size and lymph node status in multifocal/multicentric breast carcinoma. Cancer. 2002 Mar 1; 94(5):1383-90.
    View PubMed
  151. Bonnett M, Wallis T, Rossmann M, Pernick NL, Carolin KA, Segel M, Bouwman D, Visscher D. Histologic and radiographic analysis of ductal carcinoma in situ diagnosed using stereotactic incisional core breast biopsy. Mod Pathol. 2002 Feb; 15(2):95-101.
    View PubMed
  152. Reddy KB, McGowen R, Schuger L, Visscher D, Sheng S. Maspin expression inversely correlates with breast tumor progression in MMTV/TGF-alpha transgenic mouse model. Oncogene. 2001 Oct 4; 20(45):6538-43.
    View PubMed
  153. Nassar H, Wallis T, Andea A, Dey J, Adsay V, Visscher D. Clinicopathologic analysis of invasive micropapillary differentiation in breast carcinoma. Mod Pathol. 2001 Sep; 14(9):836-41.
    View PubMed
  154. Newman LA, Carolin K, Simon M, Kosir M, Hyrniuk W, Demers R, Grossbart Schwartz A, Visscher D, Peters W, Bouwman D. Impact of breast carcinoma on African-American women: the Detroit experience. Cancer. 2001 May 1; 91(9):1834-43.
    View PubMed
  155. Jimenez RE, Wallis T, Visscher DW. Centrally necrotizing carcinomas of the breast: a distinct histologic subtype with aggressive clinical behavior. Am J Surg Pathol. 2001 Mar; 25(3):331-7.
    View PubMed
  156. Visscher DW, Nanjia-Makker P, Heppner G, Shekhar PV. Tamoxifen suppresses histologic progression to atypia and DCIS in MCFIOAT xenografts, a model of early human breast cancer. Breast Cancer Res Treat. 2001 Jan; 65(1):41-7.
    View PubMed
  157. Visscher D, Jimenez RE, Grayson M 3rd, Mendelin J, Wallis T. Histopathologic analysis of chromosome aneuploidy in ductal carcinoma in situ. Hum Pathol. 2000 Feb; 31(2):201-7.
    View PubMed
  158. Pernick N, Visscher DW. Clinicopathologic analysis of FAS, FAS ligand, and other biomarkers in locally advanced breast carcinoma. Breast J. 2000; 6(4):233-41.
    View PubMed
  159. Jimenez RE, Wallis T, Tabasczka P, Visscher DW. Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization. Mod Pathol. 2000 Jan; 13(1):37-45.
    View PubMed
  160. Jimenez RE, Bongers S, Bouwman D, Segel M, Visscher DW. Clinicopathologic significance of ductal carcinoma in situ in breast core needle biopsies with invasive cancer. Am J Surg Pathol. 2000 Jan; 24(1):123-8.
    View PubMed
  161. Mendelin J, Grayson M, Wallis T, Visscher DW. Analysis of chromosome aneuploidy in breast carcinoma progression by using fluorescence in situ hybridization. Lab Invest. 1999 Apr; 79(4):387-93.
    View PubMed
  162. Jimenez RE, Visscher DW. Clinicopathologic analysis of microscopically invasive breast carcinoma. Hum Pathol. 1998 Dec; 29(12):1412-9.
    View PubMed
  163. Nangia-Makker P, Sarvis R, Visscher DW, Bailey-Penrod J, Raz A, Sarkar FH. Galectin-3 and L1 retrotransposons in human breast carcinomas. Breast Cancer Research & Treatment. 1998 May; 49(2):171-83.
    View PubMed
  164. Shekhar MP, Nangia-Makker P, Wolman SR, Tait L, Heppner GH, Visscher DW. Direct action of estrogen on sequence of progression of human preneoplastic breast disease. Am J Pathol. 1998 May; 152(5):1129-32.
    View PubMed
  165. Visscher DW, Padiyar N, Long D, Tabaczka P. Immunohistologic analysis of estrogen receptor expression in breast carcinoma precursor lesions. Breast J. 1998; 4:447-51.
  166. Visscher DW, Lawrence WD. Endometrial carcinoma: current clinical and pathological concepts. Operative Techniques in Gynecologic Surgery. 1998; 3(1):21-30.
  167. Visscher DW, Gingrich DS, Leon-Armin C, Tabaczka P, Crissman JD. Histopathologic and flow-cytometric analysis of neoplastic and benign "background" tissue in breast carcinoma resections. Anal Cell Pathol. 1998; 17(3):167-75.
    View PubMed
  168. Kattar MM, Grignon DJ, Wallis T, Haas GP, Sakr WA, Pontes JE, Visscher DW. Clinicopathologic and interphase cytogenetic analysis of papillary (chromophilic) renal cell carcinoma. Mod Pathol. 1997 Nov; 10(11):1143-50.
    View PubMed
  169. Hillman GG, Younes E, Visscher D, Hamzavi F, Kim S, Lam JS, Montecillo EJ, Ali E, Pontes JE, Puri RK, Haas GP. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4. Clin Cancer Res. 1997 Oct; 3(10):1799-806.
    View PubMed
  170. Visscher DW, Sarkar FH, Kasunic TC, Reddy KB. Clinicopathologic analysis of amphiregulin and heregulin immunostaining in breast neoplasia. Breast Cancer Research & Treatment. 1997 Aug; 45(1):75-80.
    View PubMed
  171. Visscher DW, Yadrandji S, Tabaczka P, Kraut M, Sarkar FH. Clinicopathologic analysis of k-ras, p53, and ERBB-2 gene alterations in pulmonary adenocarcinoma. Diagn Mol Pathol. 1997 Feb; 6(1):64-9.
    View PubMed
  172. Visscher DW, Sarkar FH, Kusinic TC, Fridman R, Banerjee M, Reddy KB. Phospholipase C-y immunostaining in human breast carcinoma: clinical significance and correlations with protease and growth- factor receptor species. Breast J. 1997; 3:350-6.
  173. Kosir MA, Quinn CCV, Grignon DJ, Ledbetter S, Fridman R, Visscher DW. Human prostate carcinoma cells produce extracellular heparinase. J Surg Res. 1997; 3:350-6.
  174. Kattar MM, Visscher DW. Cytometric techniques in the management of superficial transitional cell carcinoma of the bladder. Pathological Case Reviews. 1997; 2(3):122-8.
  175. Wykes SM, Visscher DW, Krawetz SA. Haploid transcripts persist in mature human spermatozoa. Mol Hum Reprod. 1997 Jan; 3(1):15-9.
    View PubMed
  176. Visscher DW, Sarkar FH, Crissman JD. Molecular genetic analysis in the pathologic evaluation of solid tumors: theory and practice. J Clin Lab Anal. 1997; 11(1):10-6.
    View PubMed
  177. Visscher DW, Wallis T, Awussah S, Mohamed A, Crissman JD. Evaluation of MYC and chromosome 8 copy number in breast carcinoma by interphase cytogenetics. Genes, Chromosomes & Cancer. 1997 Jan; 18(1):1-7.
    View PubMed
  178. Visscher DW, Gingrich DS, Buckley J, Tabaczka P, Crissman JD. Cell cycle analysis of normal, atrophic, and hyperplastic breast epithelium using two-color multiparametric flow cytometry. Anal Cell Pathol. 1996 Nov; 12(2):115-24.
    View PubMed
  179. Visscher DW, Sarkar FH, Shimoyama RK, Crissman JD. Correlation between p53 immunostaining patterns and gene sequence mutations in breast carcinoma. Diagn Mol Pathol. 1996 Sep; 5(3):187-93.
    View PubMed
  180. Visscher DW, Sarkar F, Tabaczka P, Crissman J. Clinicopathologic analysis of bcl-2 immunostaining in breast carcinoma. Mod Pathol. 1996 Jun; 9(6):642-6.
    View PubMed
  181. Visscher DW, Wallis TL, Crissman JD. Evaluation of chromosome aneuploidy in tissue sections of preinvasive breast carcinomas using interphase cytogenetics. Cancer. 1996 Jan 15; 77(2):315-20.
    View PubMed
  182. Sarkar FH, Valdivieso M, Borders J, Yao KL, Raval MM, Madan SK, Sreepathi P, Shimoyama R, Steiger Z, Visscher DW, et al. A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue. Diagn Mol Pathol. 1995 Dec; 4(4):266-73.
    View PubMed
  183. Visscher DW, Tabaczka P, Long D, Crissman JD. Clinicopathologic analysis of macrophage infiltrates in breast carcinoma. Pathology, Research & Practice. 1995 Nov; 191(11):1133-9.
    View PubMed
  184. Brooks PC, Stromblad S, Klemke R, Visscher D, Sarkar FH, Cheresh DA. Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest. 1995 Oct; 96(4):1815-22.
    View PubMed
  185. Halperin D, Visscher DW, Wallis T, Lawrence WD. Evaluation of chromosome 12 copy number in ovarian granulosa cell tumors using interphase cytogenetics. Int J Gynecol Pathol. 1995 Oct; 14(4):319-23.
    View PubMed
  186. Visscher D, Dolan P, Ottosen S, Crissman J. Geographic distribution of co-dominant DNA stemlines in breast carcinoma. Cytometry. 1995 Sep 1; 21(1):14-7.
    View PubMed
  187. Visscher DW, Wallis T, Ritchie CA. Detection of chromosome aneuploidy in breast lesions with fluorescence in situ hybridization: comparison of whole nuclei to thin tissue sections and correlation with flow cytometric DNA analysis. Cytometry. 1995 Sep 1; 21(1):95-100.
    View PubMed
  188. Visscher DW, DeMattia F, Ottosen S, Sarkar FH, Crissman JD. Biologic and clinical significance of basic fibroblast growth factor immunostaining in breast carcinoma. Mod Pathol. 1995 Aug; 8(6):665-70.
    View PubMed
  189. Nizami IY, Kissner DG, Visscher DW, Dubaybo BA. Idiopathic bronchiolitis obliterans with organizing pneumonia. An acute and life-threatening syndrome. Chest. 1995 Jul; 108(1):271-7.
    View PubMed
  190. Visscher DW, Sochacki P, Ottosen S, Wykes S, Crissman JD. Assessment and significance of diploid-range epithelial populations in DNA aneuploid breast carcinomas using multi-parametric flow cytometry. Anal Cell Pathol. 1995 Jun; 8(4):267-77.
    View PubMed
  191. Younes E, Haas GP, Visscher D, Pontes JE, Puri RK, Hillman GG. Intralesional treatment of established murine primary renal tumor with interleukin-4: localized effect on primary tumor with no impact on metastases. J Urol. 1995 Feb; 153(2):490-3.
    View PubMed
  192. Wykes SM, Nelson JE, Visscher DW, Djakiew D, Krawetz SA. Coordinate expression of the PRM1, PRM2, and TNP2 multigene locus in human testis. DNA & Cell Biology. 1995 Feb; 14(2):155-61.
    View PubMed
  193. Hillman GG, Younes E, Visscher D, Ali E, Lam JS, Montecillo E, Pontes JE, Haas GP, Puri RK. Systemic treatment with interleukin-4 induces regression of pulmonary metastases in a murine renal cell carcinoma model. Cell Immunol. 1995 Feb; 160(2):257-63.
    View PubMed
  194. Sakr WA, Grignon DJ, Visscher DW, Wolman SR, Crissman JD. Evaluating the radical prostatectomy specimen, part I. Journal of Urologic Pathology. 1995; 3:355-64.
  195. Visscher DW. Biomarkers in proliferative breast disease. Breast J. 1995; 4:222-7.
  196. Visscher DW, Hoyhtya M, Ottosen SK, Liang CM, Sarkar FH, Crissman JD, Fridman R. Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. Int J Cancer. 1994 Nov 1; 59(3):339-44.
    View PubMed
  197. Sarkar FH, Smith MR, Hoover T, Princler G, Crissman JD, Visscher DW, Longo DL, Kung HF, Raziuddin. c-erbB-2 promoter-specific DNA-binding protein isolated from human breast cancer tissues displays mitogenic activity. J Biol Chem. 1994 Apr 22; 269(16):12285-9.
    View PubMed
  198. Chakrabarty A, Hillman GG, Maughan RL, Visscher DW, Ali E, Pontes JE, Haas GP. Influence of tumor site on the therapy of murine kidney cancer. Anticancer Res. 1994 Mar-Apr; 14(2A):373-8.
    View PubMed
  199. Castellani R, Visscher DW, Wykes S, Sarkar FH, Crissman JD. Interaction of transforming growth factor-alpha and epidermal growth factor receptor in breast carcinoma. An immunohistologic study. Cancer. 1994 Jan 15; 73(2):344-9.
    View PubMed
  200. Visscher DW, Sloane BF, Sameni M, Babiarz JW, Jacobson J, Crissman JD. Clinicopathologic significance of cathepsin B immunostaining in transitional neoplasia. Mod Pathol. 1994 Jan; 7(1):76-81.
    View PubMed
  201. Visscher DW, Crissman JD. Dissociation of intact cells from tumors and normal tissues. Methods Cell Biol. 1994; 41:1-13.
    View PubMed
  202. Visscher DW, Lawrence WD, Boman S. Angiogenesis in breast carcinoma--clinicopathologic relevance and potential use as a quantifiable surrogate endpoint biomarker. J Cell Biochem Suppl. 1994; 19:146-52.
    View PubMed
  203. Micale MA, Visscher DW, Gulino SE, Wolman SR. Chromosomal aneuploidy in proliferative breast disease. Hum Pathol. 1994 Jan; 25(1):29-35.
    View PubMed
  204. Visscher DW, Sarkar FH, Wolman SR, Bedrossian CW. Theory and methodology of evaluating genetic alterations. Diagn Cytopathol. 1994; 10(3):289-98.
    View PubMed
  205. Visscher D, Castellani R, Sarkar FH, Wykes SM, Crissman, JD. Cumulative abnormal expression of ERBB-2, EGFR and p53 genes and clinical disease progression of breast carcinoma. Breast Cancer Res Treat. 1994; 28:261-6.
  206. Visscher DW, Sloane B, Sakr W, Sameni M, Weaver D, Bouwman D, Crissman JD. Clinicopathologic significance of cathepsin B and urokinase-type plasminogen activator immunostaining in colorectal adenocarcinoma. The International Journal of Sugical Pathology. 1994; 1(4):227-34.
  207. Visscher DW, Castellani R, Wykes SM, Sarkar FH, Hussain ME. Concurrent abnormal expression of ERBB-2, EGFR, and p53 genes and clinical disease progression of breast carcinoma. Breast Cancer Research & Treatment. 1993 Dec; 28(3):261-6.
    View PubMed
  208. Hussain MH, Powell I, Zaki N, Maciorowski Z, Sakr W, KuKuruga M, Visscher D, Haas GP, Pontes JE, Ensley JF. Flow cytometric DNA analysis of fresh prostatic resections. Correlation with conventional prognostic parameters in patients with prostate cancer. Cancer. 1993 Nov 15; 72(10):3012-9.
    View PubMed
  209. Visscher DW, VanBree G, Ottosen S, Wykes S, Crissman JD. Flow cytometric enumeration and kinetic analysis of inflammatory cell populations in breast carcinomas. Anal Cell Pathol. 1993 Nov; 5(6):321-30.
    View PubMed
  210. Visscher DW, Sarkar FH, Wykes S, Kothari K, Macoska J, Crissman J. Clinicopathologic significance of p53 immunostaining in adenocarcinoma of the breast. Archives of Pathology & Laboratory Medicine. 1993 Oct; 117(10):973-6.
    View PubMed
  211. Visscher DW, Sarkar FH, Sakr W, Crissman J. Immunohistologic analysis of invasive phenotype in breast carcinoma. A clinicopathologic study. Pathology, Research & Practice. 1993 Sep; 189(8):867-72.
    View PubMed
  212. Sarkar FH, Visscher DW, Crissman JD. Quantitative analysis of Her-2/neu (ERBB2) gene expression using reverse transcriptase polymerase chain reaction. Diagn Mol Pathol. 1993 Sep; 2(3):210-8.
    View PubMed
  213. Visscher DW, Shaheen C, Drozdowicz S, Crissman JD. Image cytophotometric DNA histogram heterogeneity in adenocarcinoma of the breast. Analytical & Quantitative Cytology & Histology. 1993 Jun; 15(3):206-12.
    View PubMed
  214. Visscher DW, Sarkar F, LoRusso P, Sakr W, Ottosen S, Wykes S, Crissman JD. Immunohistologic evaluation of invasion-associated proteases in breast carcinoma. Mod Pathol. 1993 May; 6(3):302-6.
    View PubMed
  215. Visscher DW, Smilanetz S, Drozdowicz S, Wykes SM. Prognostic significance of image morphometric microvessel enumeration in breast carcinoma. Analytical & Quantitative Cytology & Histology. 1993 Apr; 15(2):88-92.
    View PubMed
  216. Crissman JD, Visscher DW, Sakr W. Premalignant lesions of the upper aerodigestive tract: pathologic classification. J Cell Biochem Suppl. 1993; 17F:49-56.
    View PubMed
  217. Visscher DW, Micale MA, Crissman JD. Pathological and biological relevance of cytophotometric DNA content to breast carcinoma genetic progression. J Cell Biochem Suppl. 1993; 17G:114-22.
    View PubMed
  218. Crissman JD, Visscher DW, Sarkar FH. Premalignant lesions of the upper aerodigestive tract: biomarkers of genetic alterations, proliferation, and differentiation. J Cell Biochem Suppl. 1993; 17F:192-8.
    View PubMed
  219. Sarkar FH, Visscher DW. Human cancer: molecular genetic and viral concepts and their influence in cytodiagnosis. Diagn Cytopathol. 1993; 9(3):333-42; discussion 342-4.
    View PubMed
  220. Visscher DW, Shaheen C, Drozdowicz S, Crissman JD. Clonal DNA content heterogeneity in adenocarcinoma of the breast. Analy and Quant Cytol and Histol. 1993; 15(3):206-12.
  221. Visscher DW. Lobular carcinoma in situ of the breast. American Society of Clinical Pathologists Check Sample Case TD 93-96. 1993; 0: 0.
  222. Wolman SR, Pauley RJ, Mohamed AN, Dawson PJ, Visscher DW, Sarkar FH. Genetic markers as prognostic indicators in breast cancer. Cancer. 1992 Sep 15; 70(6 Suppl):1765-74.
    View PubMed
  223. Sarkar FH, Visscher DW, Kintanar EB, Zarbo RJ, Crissman JD. Sinonasal Schneiderian papillomas: human papillomavirus typing by polymerase chain reaction. Mod Pathol. 1992 May; 5(3):329-32.
    View PubMed
  224. Visscher DW, Wykes S, Kubus J, Crissman JD. Comparison of PCNA/cyclin immunohistochemistry with flow cytometric S-phase fraction in breast cancer. Breast Cancer Research & Treatment. 1992; 22(2):111-8.
    View PubMed
  225. Chakrabarty A, Hillman GG, Maughan RL, Dybal EJ, Visscher DW, Pontes JE, Haas GP. Immunotherapy and radiation therapy combined for the treatment of murine renal carcinoma. Surg Forum. 1992; 43:758-60.
  226. Visscher DW, Sarkar FH, Crissman JD. Correlation of DNA ploidy with c-erbB-2 expression in preinvasive and invasive breast tumors. Analytical & Quantitative Cytology & Histology. 1991 Dec; 13(6):418-24.
    View PubMed
  227. Visscher DW, Wykes S, Zarbo RJ, Crissman JD. Multiparametric evaluation of flow cytometric synthesis phase fraction determination in dual-labelled breast carcinomas. Analytical & Quantitative Cytology & Histology. 1991 Aug; 13(4):246-52.
    View PubMed
  228. Visscher D, Carey J, Oh H, Turza N, Kupin W, Venkat KK, Zarbo R. Histologic and immunophenotypic evaluation of pretreatment renal biopsies in OKT3-treated allograft rejections. Transplantation. 1991 May; 51(5):1023-8.
    View PubMed
  229. Sarin RR, Sangal AK, Schubert TT, Visscher D. Gastrocolic fistula with pyloric stenosis and benign gastric ulcer. South Med J. 1991 May; 84(5):665-6.
    View PubMed
  230. Venkat KK, Tkach D, Kupin W, Mozes M, Oh HK, Raman BK, Visscher D, Lee MW. Reversal of cyclosporine-associated hemolytic-uremic syndrome by plasma exchange with fresh-frozen plasma replacement in renal transplant recipients. Transplant Proc. 1991 Feb; 23(1 Pt 2):1256-7.
    View PubMed
  231. Crissman JD, Visscher DW, Kubus J. Image cytophotometric DNA analysis of atypical hyperplasias and intraductal carcinomas of the breast. Archives of Pathology & Laboratory Medicine. 1990 Dec; 114(12):1249-53.
    View PubMed
  232. Visscher DW, Zarbo RJ, Ma CK, Sakr WA, Crissman JD. Flow cytometric DNA and clinicopathologic analysis of Dukes' A&B colonic adenocarcinomas: a retrospective study. Mod Pathol. 1990 Nov; 3(6):709-12.
    View PubMed
  233. Visscher DW, Zarbo RJ, Trojanowski JQ, Sakr W, Crissman JD. Neuroendocrine differentiation in poorly differentiated lung carcinomas: a light microscopic and immunohistologic study. Mod Pathol. 1990 Jul; 3(4):508-12.
    View PubMed
  234. Zarbo RJ, Gown AM, Nagle RB, Visscher DW, Crissman JD. Anomalous cytokeratin expression in malignant melanoma: one- and two-dimensional western blot analysis and immunohistochemical survey of 100 melanomas. Mod Pathol. 1990 Jul; 3(4):494-501.
    View PubMed
  235. Schweitzer VG, Visscher D. Photodynamic therapy for treatment of AIDS-related oral Kaposi's sarcoma. Otolaryngology - Head & Neck Surgery. 1990 Jun; 102(6):639-49.
    View PubMed
  236. Gaffey MJ, Mills SE, Askin FB, Ross GW, Sale GE, Kulander BG, Visscher DW, Yousem SA, Colby TV. Clear cell tumor of the lung. A clinicopathologic, immunohistochemical, and ultrastructural study of eight cases. Am J Surg Pathol. 1990 Mar; 14(3):248-59.
    View PubMed
  237. Visscher DW, Zarbo RJ, Jacobsen G, Kambouris A, Talpos G, Sakr W, Crissman JD. Multiparametric deoxyribonucleic acid and cell cycle analysis of breast carcinomas by flow cytometry. Clinicopathologic correlations. Lab Invest. 1990 Mar; 62(3):370-8.
    View PubMed
  238. Visscher DW, Zarbo RJ, Greenawald KA, Crissman JD. Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast. Pathol Annu. 1990; 25 Pt 1:171-210.
    View PubMed
  239. Zarbo RJ, Visscher DW, Crissman JD. Two-color multiparametric method for flow cytometric DNA analysis of carcinomas using staining for cytokeratin and leukocyte-common antigen. Analytical & Quantitative Cytology & Histology. 1989 Dec; 11(6):391-402.
    View PubMed
  240. Visscher DW, Talerman A, Rivera LR, Mazur MT. Adenocarcinoma of the rete testis with a spindle cell component. A possible metaplastic carcinoma. Cancer. 1989 Aug 1; 64(3):770-5.
    View PubMed
  241. Visscher D, Cooper PH, Zarbo RJ, Crissman JD. Cutaneous neuroendocrine (Merkel cell) carcinoma: an immunophenotypic, clinicopathologic, and flow cytometric study. Mod Pathol. 1989 Jul; 2(4):331-8.
    View PubMed
  242. Oh HK, Kupin W, Madrazo B, Turza N, Venkat KK, Langnas A, Parker D, Visscher D. Evaluation of the renal allograft by quantitative duplex sonography and radioisotope renogram. Transplant Proc. 1989 Feb; 21(1 Pt 2):1917-8.
    View PubMed
  243. Crissman JD, Zarbo RJ, Ma CK, Visscher DW. Histopathologic parameters and DNA analysis in colorectal adenocarcinomas. Pathol Annu. 1989; 24 Pt 2:103-47.
    View PubMed
  244. Visscher D, Churg A, Katzenstein AL. Significance of crystalline inclusions in lung granulomas. Mod Pathol. 1988 Nov; 1(6):415-9.
    View PubMed
  245. Rubin E, Visscher DW, Alexander RW, Urist MM, Maddox WA. Proliferative disease and atypia in biopsies performed for nonpalpable lesions detected mammographically. Cancer. 1988 May 15; 61(10):2077-82.
    View PubMed
  246. Visscher DW, Alexander RW, Dempsey TR. Case report 472: Heretical giant cell tumor in the diaphysis of the ulna in a 7-month-old boy. Skeletal Radiol. 1988; 17(4):285-8.
    View PubMed
  247. Visscher DW, Zarbo RJ, Crissman JD. Application of monoclonal antibodies to high and low molecular weight cytokeratins in the differential diagnosis of human carcinomas. Surgical Pathology 1(4). 1988; 0: 0.
  248. Urist MM, O'Brien CJ, Soong SJ, Visscher DW, Maddox WA. Squamous cell carcinoma of the buccal mucosa: analysis of prognostic factors. Am J Surg. 1987 Oct; 154(4):411-4.
    View PubMed
  249. Treger TR, Visscher DW, Bartlett MS, Smith JW. Diagnosis of pulmonary infection caused by Aspergillus: usefulness of respiratory cultures. J Infect Dis. 1985 Sep; 152(3):572-6.
    View PubMed
  250. Brier ME, Mayer PR, Brier RA, Visscher D, Luft FC, Aronoff GR. Relationship between rat renal accumulation of gentamicin, tobramycin, and netilmicin and their nephrotoxicities. Antimicrobial Agents & Chemotherapy. 1985 May; 27(5):812-6.
    View PubMed
  251. Luft FC, Visscher DW, Nierste DM, Blase DK, Walker NA, Aronoff GR. Ceftazidime nephrotoxicity in rats. Antimicrobial Agents & Chemotherapy. 1984 Apr; 25(4):513-4.
    View PubMed
  252. Visscher DW, Miles BL, Waller BF. Tunneled ("bridged") left anterior descending coronary artery in a newborn without clinical or morphologic evidence of myocardial ischemia. Cathet Cardiovasc Diagn. 1983; 9(5):493-6.
    View PubMed